Li Zhang - Concepedia

Author

Li Zhang

Huazhong University of Science and Technology ORCID

Also Known As

L Zhang, L. Zhang, LI ZHANG, Li ZHANG, Li Zhang, Luzhen Zhang, Ping Zhao, Yi Xiang

186

Publications

16.1K

Citations

H-Index

157

Concepts

All Affiliations

Huazhong University of Science and Technology Tongji Hospital Sun Yat-sen University Chinese Academy of Medical Sciences & Peking Union Medical College Sun Yat-sen University Cancer Center

About

Li Zhang is an author at Huazhong University of Science and Technology specializing in medicine, lung cancer, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	29	3K
2	Engineering	7	7	361
3	Health Sciences	3	3	277
4	Business	2	2	56
5	Natural Sciences	1	1	18

Li Zhang

Publications

15.6K

Citations

H-Index

Page 1

	Year	Citations
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China Chaomin Wu, Yanping Cai, Jiaan Xia, JAMA Internal Medicine	2020	8.6K
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients Jing Liu, Sumeng Li, Jia Liu, EBioMedicine	2020	1.7K
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China Li Zhang, Fangfang Zhu, Li Xie, Annals of Oncology Virus EpidemiologyMedicineClinical CharacteristicsClinical EpidemiologyCovid-19-infected Cancer Patients	2020	1.5K
Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With <i>EGFR</i>-Mutated, MET Factor–Dysregulated Non–Small-Cell Lung Cancer Yi‐Long Wu, Li Zhang, Dong‐Wan Kim, Journal of Clinical Oncology	2018	327
Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation Man Yu, Zhengxin Peng, Min Qin, Molecular Cell Tumor ImmunologyAnti-pd-1 ImmunotherapyCancer ImmunosurveillanceImmunologyTumor Immunity	2021	230
Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial Jin‐Ji Yang, Caicun Zhou, Yi-Sheng Huang, The Lancet Respiratory Medicine Neuro-oncologyMultiple Brain MetastasesRadiation TherapyMedicineCancer Treatment	2017	183
EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey Yasushi Yatabe, Keith M. Kerr, Ahmad Rusdan Handoyo Utomo, Journal of Thoracic Oncology	2014	182
Longitudinal Characteristics of Lymphocyte Responses and Cytokine Profiles in the Peripheral Blood of SARS-CoV-2 Infected Patients Jing Liu, Sumeng Li, Jia Liu, SSRN Electronic Journal	2020	150
Enhanced degradation of organic contaminants by zero-valent iron/sulfite process under simulated sunlight irradiation Pengchao Xie, Li Zhang, Jinhui Chen, Water Research Advanced Oxidation ProcessEnvironmental ChemistryChemical EngineeringEngineeringDecontamination	2018	123
Cerebrospinal Fluid Concentrations of Gefitinib in Patients With Lung Adenocarcinoma Jing Zhao, Minjiang Chen, Wei Zhong, Clinical Lung Cancer MedicineCerebrospinal FluidLung AdenocarcinomaPathologyOncology	2012	120

Page 1